Development of human connective tissue mast cells from purified blood monocytes.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 1454453)

Published in Immunology on March 01, 1984

Authors

B M Czarnetzki, C G Figdor, G Kolde, T Vroom, R Aalberse, J E de Vries

Articles cited by this

A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (1977) 12.57

Lymphokine enhances the expression and synthesis of Ia antigens on cultured mouse peritoneal macrophages. J Exp Med (1980) 5.24

Mast cell clones: a model for the analysis of cellular maturation. J Cell Biol (1982) 1.91

Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. J Immunol (1973) 1.89

Development of mast cells in vitro. II. Biologic function of cultured mast cells. J Immunol (1977) 1.48

Mast cell heterogeneity: derivation and function, with emphasis on the intestine. J Allergy Clin Immunol (1982) 1.46

Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27

Mast cell growth on fibroblast monolayers: two-cell entities. Immunology (1982) 1.10

Nature of the thymus dependency of mucosal mast cells. III. Mucosal mast cells in nude mice and nude rats, in B rats and in a child with the Di George syndrome. Int Arch Allergy Appl Immunol (1981) 1.05

Mast cell membrane antigens and Fc receptors in anaphylaxis. I. Products of the major histocompatibility complex involved in alloantibody-induced mast cell activation. Immunology (1979) 0.99

Intestinal mast cells and globule leucocytes: role of the thymus on their presence and proliferation during a Trichinella spiralis infection in the rat. Int Arch Allergy Appl Immunol (1979) 0.96

In vitro generation of mast cell-like cells from human peripheral mononuclear phagocytes. Int Arch Allergy Appl Immunol (1983) 0.90

Relationship between histocompatibility antigens, other surface determinants and the IgE receptor on rat mast cells. Eur J Immunol (1979) 0.86

In vitro differentiation of rat peritoneal macrophages into mast cells: an enzymecytochemical study. Blut (1982) 0.86

Evidence that tissue mast cells derive from mononuclear phagocytes. Int Arch Allergy Appl Immunol (1982) 0.80

[Origin of rat tissue mast cells with quantitative cytological data on sterile peritonitis]. Virchows Arch B Cell Pathol (1971) 0.79

Cultures of mast cell-like (MCL) cells from human pleural exudate cells. Blut (1983) 0.79

Studies on isolated mast cells from guinea pig, dog, calf and man [proceedings]. Agents Actions (1978) 0.78

Articles by these authors

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 16.28

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell (2000) 14.43

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med (1991) 9.27

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell (2000) 8.34

Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A (1993) 4.45

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med (1994) 3.94

Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet (1994) 3.45

Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol (1993) 3.36

Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature (1989) 3.36

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med (1996) 3.30

Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today (1994) 3.25

Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol (1993) 3.14

Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med (1998) 3.01

DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol (2000) 2.98

Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J Immunol (1988) 2.95

Interleukin-10. Curr Opin Immunol (1992) 2.85

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med (1994) 2.70

Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen. J Immunol (1985) 2.70

IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol (1992) 2.67

A novel receptor involved in T-cell activation. Nature (1995) 2.56

Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood (1990) 2.48

Asthma at 8 years of age in children born by caesarean section. Thorax (2008) 2.45

IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol (1993) 2.44

A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature (1997) 2.44

B cell growth-promoting activity of recombinant human interleukin 4. J Immunol (1987) 2.31

Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr Opin Cell Biol (2000) 2.30

Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J Exp Med (1991) 2.27

Recombinant interleukin 4 promotes the growth of human T cells. J Immunol (1987) 2.13

A monoclonal antibody (NKI-L16) directed against a unique epitope on the alpha-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions. J Immunol (1988) 2.13

Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production. J Exp Med (1990) 2.09

Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J Immunol (1991) 2.07

[Interval appendectomy as indicated rather than as routine therapy: fewer operations and shorter hospital stays]. Ned Tijdschr Geneeskd (2007) 1.98

Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity (1997) 1.97

Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood (2001) 1.88

Isolation of functionally different human monocytes by counterflow centrifugation elutriation. Blood (1982) 1.83

The threshold at which substrate nanogroove dimensions may influence fibroblast alignment and adhesion. Biomaterials (2007) 1.82

Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol (1998) 1.81

Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med (1996) 1.80

Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines. Hybridoma (1983) 1.79

Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. J Immunol (1990) 1.79

Cell biology beyond the diffraction limit: near-field scanning optical microscopy. J Cell Sci (2001) 1.77

De-novo expression of CD44 and survival in gastric cancer. Lancet (1993) 1.75

Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion (1997) 1.75

3D single-particle tracking and optical trap measurements on adhesion proteins. Cytometry (1999) 1.72

Activation of LFA-1 through a Ca2(+)-dependent epitope stimulates lymphocyte adhesion. J Cell Biol (1991) 1.72

Alpha-interferon treatment of patient with hyper IgE syndrome. Lancet (1989) 1.70

Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma. J Immunol (1988) 1.67

The role of monocytes in human lymphocyte activation by mitogens. J Immunol (1979) 1.67

Antibodies and antigen expression in human melanoma detected by the immune adherence test. Int J Cancer (1975) 1.65

Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA-1, Mo-1 and p150,95. Eur J Immunol (1985) 1.64

IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol (1993) 1.62

Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. J Biol Chem (2000) 1.61

A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med (1999) 1.60

Ins and outs of LFA-1. Immunol Today (1995) 1.59

Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem (1994) 1.58

Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Immunol (1990) 1.58

The actin cytoskeleton regulates LFA-1 ligand binding through avidity rather than affinity changes. J Biol Chem (1999) 1.56

Dual role of the actin cytoskeleton in regulating cell adhesion mediated by the integrin lymphocyte function-associated molecule-1. Mol Biol Cell (1997) 1.54

Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol (1995) 1.54

Breast feeding, parental allergy and asthma in children followed for 8 years. The PIAMA birth cohort study. Thorax (2009) 1.54

Transforming growth factor-beta directs IgA switching in human B cells. J Immunol (1992) 1.53

Mast cells. Int J Dermatol (1995) 1.52

Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Pathol (1993) 1.51

Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. J Immunol (1993) 1.51

IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol (1992) 1.51

Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer (2006) 1.50

Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol (1995) 1.50

An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med (1993) 1.50

Role of p150,95 in adhesion, migration, chemotaxis and phagocytosis of human monocytes. Eur J Immunol (1987) 1.48

Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide-dexamethasone pulse therapy. Br J Dermatol (1998) 1.47

Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res (1990) 1.46

Human mast cells produce IL-8. J Immunol (1993) 1.44

Biomolecular interactions measured by atomic force microscopy. Biophys J (2000) 1.43

DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur J Immunol (2000) 1.41

Interleukin-4 mediates CD8 induction on human CD4+ T-cell clones. Nature (1988) 1.41

High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia. Blood (1999) 1.41

The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J Exp Med (1993) 1.41

Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol (1993) 1.40

A centrifugal elutriation system of separating small numbers of cells. J Immunol Methods (1984) 1.40

[Recurrent nodular panniculitis in alpha 1-antitrypsin deficiency. Successful dapsone therapy]. Hautarzt (1993) 1.39

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol (2004) 1.39

IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. J Immunol (1988) 1.38

Simultaneous height and adhesion imaging of antibody-antigen interactions by atomic force microscopy. Biophys J (1998) 1.37

Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J Exp Med (1997) 1.37

Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J Immunol (1997) 1.37

Extracellular Ca2+ modulates leukocyte function-associated antigen-1 cell surface distribution on T lymphocytes and consequently affects cell adhesion. J Cell Biol (1994) 1.36

Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model. Cancer Res (2000) 1.36

Properties of a panel of monoclonal antibodies which react with the human T cell antigen receptor on the leukemic line HPB-ALL and a subset of normal peripheral blood T lymphocytes. J Immunol (1986) 1.35

Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. J Immunol (1999) 1.35

Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34

Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells. Science (1986) 1.34

Adhesion of T and B lymphocytes to extracellular matrix and endothelial cells can be regulated through the beta subunit of VLA. J Cell Biol (1992) 1.33